摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-ethyl-2-methyl-5-nitro-6-(4,5,7,8-tetrahydro-thieno[2,3-d]azepin-6-yl)-3H-pyrimidin-4-one

中文名称
——
中文别名
——
英文名称
3-ethyl-2-methyl-5-nitro-6-(4,5,7,8-tetrahydro-thieno[2,3-d]azepin-6-yl)-3H-pyrimidin-4-one
英文别名
3-Ethyl-2-methyl-5-nitro-6-(4,5,7,8-tetrahydrothieno[2,3-d]azepin-6-yl)pyrimidin-4-one
3-ethyl-2-methyl-5-nitro-6-(4,5,7,8-tetrahydro-thieno[2,3-d]azepin-6-yl)-3H-pyrimidin-4-one化学式
CAS
——
化学式
C15H18N4O3S
mdl
——
分子量
334.399
InChiKey
LVUWMLIPQLWWLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    110
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    2-methyl-5-nitro-6-(4,5,7,8-tetrahydro-thieno[2,3-d]azepin-6-yl)-3H-pyrimidin-4-one 、 溴乙烷potassium carbonate 作用下, 以 DMF (N,N-dimethyl-formamide) 为溶剂, 生成 3-ethyl-2-methyl-5-nitro-6-(4,5,7,8-tetrahydro-thieno[2,3-d]azepin-6-yl)-3H-pyrimidin-4-one 、 6-(6-ethoxy-2-methyl-5-nitro-pyrimidin-4-yl)-5,6,7,8-tetrahydro-4H-thieno[2,3-d]azepine
    参考文献:
    名称:
    mGluR antagonists and a method for their synthesis
    摘要:
    本发明涉及硝基和氰基1,2,4,5-四氢杂环辛基嘧啶衍生物及其药学上可接受的盐。本发明还涉及含有这种化合物的药物以及制备这种化合物的过程。本发明的化合物是I组mGluR拮抗剂,因此对于控制或预防急性和/或慢性神经系统疾病非常有用。
    公开号:
    US06369222B1
点击查看最新优质反应信息

文献信息

  • Novel mGluR antagonists and a method for their synthesis
    申请人:——
    公开号:US20020045635A1
    公开(公告)日:2002-04-18
    The invention relates to nitro- and cyano-1,2,4,5-tetrahydro-heterocycloazepinyl pyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to medicaments containing such compounds and a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control or prevention of acute and/or chronic neurological disorders.
    本发明涉及硝基和氰基1,2,4,5-四氢杂环庚啶基嘧啶衍生物及其药学上可接受的盐。本发明还涉及含有这种化合物的药物以及制备这种化合物的方法。本发明的化合物是I群mGluR拮抗剂,因此对于控制或预防急性和/或慢性神经系统疾病是有用的。
  • TETRAHYDRO-HETEROCYCLOAZEPINYL PYRIMIDINE DERIVATIVES
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:EP1303521A1
    公开(公告)日:2003-04-23
  • US6369222B1
    申请人:——
    公开号:US6369222B1
    公开(公告)日:2002-04-09
  • [EN] TETRAHYDRO-HETEROCYCLOAZEPINYL PYRIMIDINE DERIVATIVES<br/>[FR] DERIVES DE TETRAHYDRO-HETEROCYCLOAZEPINYL PYRIMIDINE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2002006288A1
    公开(公告)日:2002-01-24
    The invention relates to compounds of the general formula (I) wherein HET and R?1 to R12¿ have the significances as defined in the specification, as well as their phamaceutically acceptable salts. The invention further relates to medicaments containing such compounds and a process for the preparation of such compounds. The compounds of formula (I) are group (I) mGluR antagonists and are therefore useful for the control or prevention of acute and/or chronic neurological disorders.
  • mGluR antagonists and a method for their synthesis
    申请人:Hoffmann-La Roche Inc.
    公开号:US06369222B1
    公开(公告)日:2002-04-09
    The invention relates to nitro- and cyano-1,2,4,5-tetrahydro-heterocycloazepinyl pyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to medicaments containing such compounds and a process for the preparation of such compounds. The compounds of the invention are group I mGluR antagonists and are therefore useful for the control or prevention of acute and/or chronic neurological disorders.
    本发明涉及硝基和氰基1,2,4,5-四氢杂环辛基嘧啶衍生物及其药学上可接受的盐。本发明还涉及含有这种化合物的药物以及制备这种化合物的过程。本发明的化合物是I组mGluR拮抗剂,因此对于控制或预防急性和/或慢性神经系统疾病非常有用。
查看更多